These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
176 related items for PubMed ID: 36648741
1. Blood TGF-β1 and miRNA-21-5p levels predict renal fibrosis and outcome in IgA nephropathy. Bharti N, Agrawal V, Kamthan S, Prasad N, Agarwal V. Int Urol Nephrol; 2023 Jun; 55(6):1557-1564. PubMed ID: 36648741 [Abstract] [Full Text] [Related]
2. Application of Oxford classification, and overexpression of transforming growth factor-β1 and immunoglobulins in immunoglobulin A nephropathy: correlation with World Health Organization classification of immunoglobulin A nephropathy in a Chinese patient cohort. Meng H, Zhang L, E X, Ye F, Li H, Han C, Yamakawa M, Jin X. Transl Res; 2014 Jan; 163(1):8-18. PubMed ID: 23891568 [Abstract] [Full Text] [Related]
3. Serum miR-192 Is Related to Tubulointerstitial Lesion and Short-Term Disease Progression in IgA Nephropathy. Fan Q, Lu R, Zhu M, Yan Y, Guo X, Qian Y, Zhang L, Dai H, Ni Z, Gu L. Nephron; 2019 Jan; 142(3):195-207. PubMed ID: 30808829 [Abstract] [Full Text] [Related]
4. Urinary miR-185-5p is a biomarker of renal tubulointerstitial fibrosis in IgA nephropathy. Duan ZY, Bu R, Liang S, Chen XZ, Zhang C, Zhang QY, Li JJ, Chen XM, Cai GY. Front Immunol; 2024 Jan; 15():1326026. PubMed ID: 38426107 [Abstract] [Full Text] [Related]
5. Expression and significance of TGF-beta1/Smad signaling pathway in children with IgA nephropathy. Wu W, Jiang XY, Zhang QL, Mo Y, Sun LZ, Chen SM. World J Pediatr; 2009 Aug; 5(3):211-5. PubMed ID: 19693466 [Abstract] [Full Text] [Related]
6. Circulating MiR-29a, Possible Use as a Biomarker for Monitoring IgA Nephropathy. Hu H, Wan Q, Li T, Qi D, Dong X, Xu Y, Chen H, Liu H, Huang H, Wei C, Zhou W, Jiang S, Mo Z, Liao F, Xu Q, He Y. Iran J Kidney Dis; 2020 Mar; 14(2):107-118. PubMed ID: 32165595 [Abstract] [Full Text] [Related]
7. Urinary exosomal miRNA-451a can be used as a potential noninvasive biomarker for diagnosis, reflecting tubulointerstitial damage and therapeutic response in IgA nephropathy. Zhang Q, Zhao Y, Luo Y, Guo S, Hou H, Han X, Zhou Y. Ren Fail; 2024 Dec; 46(1):2319326. PubMed ID: 38379319 [Abstract] [Full Text] [Related]
8. Efficacy of Modified Huangqi Chifeng decoction in alleviating renal fibrosis in rats with IgA nephropathy by inhibiting the TGF-β1/Smad3 signaling pathway through exosome regulation. Zhao M, Yang B, Li L, Si Y, Chang M, Ma S, Li R, Wang Y, Zhang Y. J Ethnopharmacol; 2022 Mar 01; 285():114795. PubMed ID: 34737009 [Abstract] [Full Text] [Related]
9. Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy. Chen X, Peng S, Zeng H, Fu A, Zhu Q. Indian J Pharmacol; 2015 Mar 01; 47(1):27-33. PubMed ID: 25821307 [Abstract] [Full Text] [Related]
10. Discovery of Fibrinogen γ-chain as a potential urinary biomarker for renal interstitial fibrosis in IgA nephropathy. Guan J, Wang M, Zhao M, Ni W, Zhang M. BMC Nephrol; 2023 Mar 20; 24(1):60. PubMed ID: 36941570 [Abstract] [Full Text] [Related]
11. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy. Liang S, Cai GY, Duan ZY, Liu SW, Wu J, Lv Y, Hou K, Li ZX, Zhang XG, Chen XM. BMC Nephrol; 2017 Feb 15; 18(1):63. PubMed ID: 28201996 [Abstract] [Full Text] [Related]
12. Expression of P311, a transforming growth factor beta latency-associated protein-binding protein, in human kidneys with IgA nephropathy. Wang F, Xie X, Fan J, Wang L, Guo D, Yang L, Ma X, Zhang L, Li Z. Int Urol Nephrol; 2010 Sep 15; 42(3):811-9. PubMed ID: 19946746 [Abstract] [Full Text] [Related]
13. Primary IgA nephropathy is more severe in TGF-beta1 high secretor patients. Brezzi B, Del Prete D, Lupo A, Magistroni R, Gomez-Lira M, Bernich P, Anglani F, Mezzabotta F, Turco A, Furci L, Ceol M, Antonucci F, Abaterusso C, Bonfante L, D'Angelo A, Albertazzi A, Gambaro G. J Nephrol; 2009 Sep 15; 22(6):747-59. PubMed ID: 19967654 [Abstract] [Full Text] [Related]
14. Differential expression of urinary exosomal microRNAs in IgA nephropathy. Min QH, Chen XM, Zou YQ, Zhang J, Li J, Wang Y, Li SQ, Gao QF, Sun F, Liu J, Xu YM, Lin J, Huang LF, Huang B, Wang XZ. J Clin Lab Anal; 2018 Feb 15; 32(2):. PubMed ID: 28383146 [Abstract] [Full Text] [Related]
15. The Role of Renal Macrophage, AIM, and TGF-β1 Expression in Renal Fibrosis Progression in IgAN Patients. Yang M, Liu JW, Zhang YT, Wu G. Front Immunol; 2021 Feb 15; 12():646650. PubMed ID: 34194427 [Abstract] [Full Text] [Related]
16. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy. Lim CS, Kim YS, Chae DW, Ahn C, Han JS, Kim S, Lee JS, Kim IS. Clin Nephrol; 2005 Feb 15; 63(2):61-7. PubMed ID: 15730046 [Abstract] [Full Text] [Related]
17. Evaluation of TGF-β1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: A clinical correlation. Shuiai Z, Huijun S, Weizhong G, Aimin L, Jianhua M. Clinics (Sao Paulo); 2017 Feb 01; 72(2):95-102. PubMed ID: 28273242 [Abstract] [Full Text] [Related]
18. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy. Chihara Y, Ono H, Ishimitsu T, Ono Y, Ishikawa K, Rakugi H, Ogihara T, Matsuoka H. Clin Nephrol; 2006 Jun 01; 65(6):385-92. PubMed ID: 16792132 [Abstract] [Full Text] [Related]
19. Mast cells, TGF-beta1 and alpha-SMA expression in IgA nephropathy. Silva GE, Costa RS, Ravinal RC, dos Reis MA, Dantas M, Coimbra TM. Dis Markers; 2008 Jun 01; 24(3):181-90. PubMed ID: 18334740 [Abstract] [Full Text] [Related]
20. [Clinical significance of TGF-β1 in children with primary IgA nephropathy]. Zhu HT, Ru L, Guo YF. Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul 01; 16(7):749-53. PubMed ID: 25008886 [Abstract] [Full Text] [Related] Page: [Next] [New Search]